Matthew Liddelow, Chief Executive Officer and Managing Director of NeuroScientific Biopharmaceuticals (ASX:NSB) was interviewed by Morgans Senior Analyst Scott Power. Matthew detailed NSB as a company as well as their position heading into the next 12 months.